期刊
BIOMATERIALS SCIENCE
卷 10, 期 18, 页码 5081-5091出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2bm01027e
关键词
-
资金
- Imperial College Research Fellowship
Recent advances in genomics have accelerated the discovery of therapeutic targets for diseases such as cancer and wound healing. The study of how bio- and nanomaterials can alter gene expression through epigenetic mechanisms is equally fascinating, as it may lead to positive therapeutic responses without the need for additional biomolecule delivery.
Recent advances in genomics during the 1990s have made it possible to study and identify genetic and epigenetic responses of cells and tissues to various drugs and environmental factors. This has accelerated the number of targets available to treat a range of diseases from cancer to wound healing disorders. Equally interesting is the understanding of how bio- and nanomaterials alter gene expression through epigenetic mechanisms, and whether they have the potential to elicit a positive therapeutic response without requiring additional biomolecule delivery. In fact, from a cell's perspective, a biomaterial is nothing more than an environmental factor, and so it has the power to epigenetically modulate gene expression of cells in contact with it. Understanding these epigenetic interactions between biomaterials and cells will open new avenues in the development of technologies that can not only provide biological signals (i.e. drugs, growth factors) necessary for therapy and regeneration, but also intimately interact with cells to promote the expression of genes of interest. This review article aims to summarise the current state-of-the-art and progress on the development of bio- and nanomaterials to modulate the epigenome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据